Literature DB >> 31996021

IgE Contributes to Atherosclerosis and Obesity by Affecting Macrophage Polarization, Macrophage Protein Network, and Foam Cell Formation.

Xian Zhang1, Jie Li1,2, Songyuan Luo1, Minjie Wang1, Qin Huang1, Zhiyong Deng1, Caroline de Febbo1, Aida Daoui1, Pei Xiong Liew1, Galina K Sukhova1, Jari Metso3, Matti Jauhiainen3, Guo-Ping Shi1, Junli Guo1,4.   

Abstract

OBJECTIVE: By binding to its high-affinity receptor FcεR1, IgE activates mast cells, macrophages, and other inflammatory and vascular cells. Recent studies support an essential role of IgE in cardiometabolic diseases. Plasma IgE level is an independent predictor of human coronary heart disease. Yet, a direct role of IgE and its mechanisms in cardiometabolic diseases remain incompletely understood. Approach and
Results: Using atherosclerosis prone Apoe-/- mice and IgE-deficient Ige-/- mice, we demonstrated that IgE deficiency reduced atherosclerosis lesion burden, lesion lipid deposition, smooth muscle cell and endothelial cell contents, chemokine MCP (monocyte chemoattractant protein)-1 expression and macrophage accumulation. IgE deficiency also reduced bodyweight gain and increased glucose and insulin sensitivities with significantly reduced plasma cholesterol, triglyceride, insulin, and inflammatory cytokines and chemokines, including IL (interleukin)-6, IFN (interferon)-γ, and MCP-1. From atherosclerotic lesions and peritoneal macrophages from Apoe-/-Ige-/- mice that consumed an atherogenic diet, we detected reduced expression of M1 macrophage markers (CD68, MCP-1, TNF [tumor necrosis factor]-α, IL-6, and iNOS [inducible nitric oxide synthase]) but increased expression of M2 macrophage markers (Arg [arginase]-1 and IL-10) and macrophage-sterol-responsive-network molecules (complement C3, lipoprotein lipase, LDLR [low-density lipoprotein receptor]-related protein 1, and TFR [transferrin]) that suppress macrophage foam cell formation. These IgE activities can be reproduced in bone marrow-derived macrophages from wild-type mice, but muted in cells from FcεR1-deficient mice, or blocked by anti-IgE antibody or complement C3 deficiency.
CONCLUSIONS: IgE deficiency protects mice from diet-induced atherosclerosis, obesity, glucose tolerance, and insulin resistance by regulating macrophage polarization, macrophage-sterol-responsive-network gene expression, and foam cell formation.

Entities:  

Keywords:  IgE; atherosclerosis; insulin resistance; macrophages; obesity

Mesh:

Substances:

Year:  2020        PMID: 31996021      PMCID: PMC7047522          DOI: 10.1161/ATVBAHA.119.313744

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  41 in total

Review 1.  New developments in FcepsilonRI regulation, function and inhibition.

Authors:  Stefan Kraft; Jean-Pierre Kinet
Journal:  Nat Rev Immunol       Date:  2007-05       Impact factor: 53.106

Review 2.  Transcriptional control of macrophage polarization.

Authors:  Derin Tugal; Xudong Liao; Mukesh K Jain
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-05-02       Impact factor: 8.311

3.  Dietary luteolin activates browning and thermogenesis in mice through an AMPK/PGC1α pathway-mediated mechanism.

Authors:  X Zhang; Q-X Zhang; X Wang; L Zhang; W Qu; B Bao; C-A Liu; J Liu
Journal:  Int J Obes (Lond)       Date:  2016-07-05       Impact factor: 5.095

Review 4.  Recommendation on Design, Execution, and Reporting of Animal Atherosclerosis Studies: A Scientific Statement From the American Heart Association.

Authors:  Alan Daugherty; Alan R Tall; Mat J A P Daemen; Erling Falk; Edward A Fisher; Guillermo García-Cardeña; Aldons J Lusis; A Phillip Owens; Michael E Rosenfeld; Renu Virmani
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-07-20       Impact factor: 8.311

5.  Macrophage plasticity in experimental atherosclerosis.

Authors:  Jamila Khallou-Laschet; Aditi Varthaman; Giulia Fornasa; Caroline Compain; Anh-Thu Gaston; Marc Clement; Michaël Dussiot; Olivier Levillain; Stéphanie Graff-Dubois; Antonino Nicoletti; Giuseppina Caligiuri
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

6.  Active anaphylaxis in IgE-deficient mice.

Authors:  H C Oettgen; T R Martin; A Wynshaw-Boris; C Deng; J M Drazen; P Leder
Journal:  Nature       Date:  1994-08-04       Impact factor: 49.962

7.  Cardiovascular disease predictors and adipose tissue macrophage polarization: Is there a link?

Authors:  Ivana Kralova Lesna; Marek Petras; Sona Cejkova; Anna Kralova; Jiri Fronek; Libor Janousek; Filip Thieme; Tomas Tyll; Rudolf Poledne
Journal:  Eur J Prev Cardiol       Date:  2017-11-20       Impact factor: 7.804

Review 8.  IgE in allergy and asthma today.

Authors:  Hannah J Gould; Brian J Sutton
Journal:  Nat Rev Immunol       Date:  2008-03       Impact factor: 53.106

9.  Increased Plasma IgE Accelerate Atherosclerosis in Secreted IgM Deficiency.

Authors:  Dimitrios Tsiantoulas; Ilze Bot; Maria Ozsvar-Kozma; Laura Göderle; Thomas Perkmann; Karsten Hartvigsen; Daniel H Conrad; Johan Kuiper; Ziad Mallat; Christoph J Binder
Journal:  Circ Res       Date:  2016-11-30       Impact factor: 17.367

10.  Obesity and Insulin Resistance Promote Atherosclerosis through an IFNγ-Regulated Macrophage Protein Network.

Authors:  Catherine A Reardon; Amulya Lingaraju; Kelly Q Schoenfelt; Guolin Zhou; Chang Cui; Hannah Jacobs-El; Ilona Babenko; Andrew Hoofnagle; Daniel Czyz; Howard Shuman; Tomas Vaisar; Lev Becker
Journal:  Cell Rep       Date:  2018-06-05       Impact factor: 9.423

View more
  13 in total

Review 1.  Innate and adaptive immunity: the understudied driving force of heart valve disease.

Authors:  Francesca Bartoli-Leonard; Jonas Zimmer; Elena Aikawa
Journal:  Cardiovasc Res       Date:  2021-11-22       Impact factor: 10.787

Review 2.  Contribution of Dysregulated B-Cells and IgE Antibody Responses to Multiple Sclerosis.

Authors:  Malik R Seals; Monica M Moran; Jonathan D Leavenworth; Jianmei W Leavenworth
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

Review 3.  Functional Role of B Cells in Atherosclerosis.

Authors:  Shelby D Ma; Marion Mussbacher; Elena V Galkina
Journal:  Cells       Date:  2021-01-29       Impact factor: 6.600

4.  Remodeling of the tumor microenvironment via disrupting Blimp1+ effector Treg activity augments response to anti-PD-1 blockade.

Authors:  Michael L Dixon; Lin Luo; Sadashib Ghosh; Jeffrey M Grimes; Jonathan D Leavenworth; Jianmei W Leavenworth
Journal:  Mol Cancer       Date:  2021-11-20       Impact factor: 27.401

Review 5.  Macrophage Biology in Cardiovascular Diseases.

Authors:  Mitri K Khoury; Huan Yang; Bo Liu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-15       Impact factor: 8.311

Review 6.  Anti-inflammatory and Immunomodulatory Therapies in Atherosclerosis.

Authors:  Justine Deroissart; Florentina Porsch; Thomas Koller; Christoph J Binder
Journal:  Handb Exp Pharmacol       Date:  2022

7.  MK2206 attenuates atherosclerosis by inhibiting lipid accumulation, cell migration, proliferation, and inflammation.

Authors:  Ya-Qin Tang; Zhi-Wei Li; Yu-Fan Feng; Hong-Qin Yang; Cui-Liu Hou; Chi Geng; Pei-Ran Yang; Hong-Mei Zhao; Jing Wang
Journal:  Acta Pharmacol Sin       Date:  2021-07-27       Impact factor: 6.150

8.  Elevated IgE promotes cardiac fibrosis by suppressing miR-486a-5p.

Authors:  Hongmei Zhao; Hongqin Yang; Chi Geng; Yang Chen; Yaqin Tang; Zhiwei Li; Junling Pang; Ting Shu; Yu Nie; Yongshuo Liu; Kegang Jia; Jing Wang
Journal:  Theranostics       Date:  2021-06-05       Impact factor: 11.556

Review 9.  Abdominal Aortic Aneurysm: Roles of Inflammatory Cells.

Authors:  Zhen Yuan; Yi Lu; Jia Wei; Jiaqi Wu; Jin Yang; Zhejun Cai
Journal:  Front Immunol       Date:  2021-02-03       Impact factor: 7.561

Review 10.  Pathophysiology of Atherosclerotic Plaque Development-Contemporary Experience and New Directions in Research.

Authors:  Michal Kowara; Agnieszka Cudnoch-Jedrzejewska
Journal:  Int J Mol Sci       Date:  2021-03-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.